CLIA Kit for Folic Acid (FA)
VB9; Vitamin B9; Folacin; Folate; V; Itamin M; Vitamin M; Vitamin Bc; Pteroyl-L-Glutamic Acid; Pteroyl-L-Glutamate
- UOM
- FOB US$ 669.00 US$ 955.00 US$ 4,298.00 US$ 8,118.00 US$ 66,850.00
- Quantity
Overview
Properties
- Product No.CCA610Ge
- Organism SpeciesPan-species (General) Same name, Different species.
- ApplicationsChemiluminescent immunoassay for Antigen Detection.
Research use only - DownloadInstruction Manual
- CategoryHematologyReproductive scienceNutrition metabolism
Sign into your account
Share a new citation as an author
Upload your experimental result
Review

Contact us
Please fill in the blank.
Recovery
Matrices listed below were spiked with certain level of Folic Acid (FA) and the recovery rates were calculated by comparing the measured value to the expected amount of Folic Acid (FA) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 99-105 | 102 |
EDTA plasma(n=5) | 78-92 | 86 |
heparin plasma(n=5) | 96-103 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Folic Acid (FA) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Folic Acid (FA) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Folic Acid (FA) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 79-93% | 80-98% | 86-98% | 78-101% |
EDTA plasma(n=5) | 85-102% | 95-103% | 94-105% | 91-99% |
heparin plasma(n=5) | 80-101% | 97-104% | 88-99% | 79-90% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
Substrate A | 1×10mL | Substrate B | 1×2mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
7. Read RLU value immediately.

Test principle
The microplate provided in this kit has been pre-coated with a monoclonal antibody specific to Folic Acid (FA). A competitive inhibition reaction is launched between biotin labeled Folic Acid (FA) and unlabeled Folic Acid (FA) (Standards or samples) with the pre-coated antibody specific to Folic Acid (FA). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Folic Acid (FA) in the sample. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is reverse proportional to the Folic Acid (FA) level in the sample or standard.
Giveaways
Increment services
Citations
- Vitamin Status and the Development of Postoperative Cognitive Decline in Elderly Surgical Oncologic Patients.pubmed:29058145
- Folic Acid-Functionalized Hybrid Photonic Barcodes for Capture and Release of Circulating Tumor CellsPubmed:29882648
- Development of Orally Applicable, Combinatorial Drug–Loaded Nanoparticles for the Treatment of FibrosarcomaPubmed:29339136
- Role of folic acid deficiency as a possible risk factor for erectile dysfunctionPubmed: 29157083
- Low serum folic acid can be a potential independent risk factor for erectile dysfunction: a prospective case–control studyPubmed: 30547361
- Enhanced cellular uptake, transport and oral bioavailability of optimized folic acid-loaded chitosan nanoparticlesPubmed:35292282
- Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, EthiopiaPubmed:35464038